title: [Long-term medication in schizophrenic psychoses].
abstract: Schizophrenia is a relapsing disorder. The main goal of neuroleptic maintenance treatment is relapse prevention, which is empirically well proven. Availability of different kinds of treatment strategies including new antipsychotic drugs with improved risk/benefit profile allow long-term treatment to be individually tailored. Treatment guidelines developed mainly by the scientific medical societies can help the practitioner in making the right decisions.
authors.affiliation: Psychiatrische Klinik, Heinrich-Heine-Universität Düsseldorf. wolfgang.gaebel@uni-duesseldorf.de
authors.forename: W
authors.initials: W
authors.lastname: Gaebel
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008134:Long-Term Care; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents